Choose your language
Back to overview

LuMind Research Down Syndrome Foundation (LuMind RDS) launches the Down Syndrome Clinical Trials Network (DS-CTN)

The goal for the DS-CTN is to carry out clinical trials more rapidly with the readiness of clinical sites and the availability of ready-to-enroll participants with Down syndrome. The initial focus will be aimed at preventing Alzheimer’s onset in people with Down syndrome as well as support relevant observational studies.

More information: link